ID   SNU-1958
AC   CVCL_T040
DR   cancercelllines; CVCL_T040
DR   Cosmic; 2068087
DR   KCLB; 01958
DR   Wikidata; Q54955142
RX   PubMed=24141649;
WW   Info; ICLAC; -; https://iclac.org/wp-content/uploads/Cross-Contaminations_v13_distribution.xlsx
CC   Problematic cell line: Contaminated. Shown to be a LS513 derivative (ICLAC). Originally thought to originate from the ascitic fluid of a 55 year old female patient with triple-negative breast carcinoma.
CC   Part of: Seoul National University (SNU) cell line collection.
CC   Registration: International Cell Line Authentication Committee, Register of Misidentified Cell Lines; ICLAC-00539.
CC   Population: Caucasian.
CC   Doubling time: 53 hours (PubMed=24141649).
CC   Sequence variation: Mutation; HGNC; HGNC:2514; CTNNB1; Simple; p.Ala5_Ala80del (c.14_241del228); Zygosity=Homozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:6407; KRAS; Simple; p.Gly12Asp (c.35G>A); ClinVar=VCV000012582; Zygosity=Heterozygous (from parent cell line).
CC   Sequence variation: Mutation; HGNC; HGNC:11998; TP53; None_reported; -; Zygosity=- (from parent cell line).
CC   Misspelling: SNU-1598; Cosmic=2068087.
CC   Derived from site: In situ; Intestine, ileocecal valve; UBERON=UBERON_0000569.
ST   Source(s): KCLB=01958; PubMed=24141649
ST   Amelogenin: X
ST   CSF1PO: 10,13
ST   D13S317: 9,10
ST   D3S1358: 15
ST   D5S818: 9,11
ST   D7S820: 8,11
ST   FGA: 19,21
ST   TPOX: 8
ST   vWA: 16,17
DI   NCIt; C5543; Cecum adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_1386 ! LS513
SX   Male
AG   63Y
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 10-04-25; Version: 23
//
RX   PubMed=24141649; DOI=10.3892/ijo.2013.2144;
RA   Ku, Ja-Lok
RA   Park, Sung-Chan
RA   Kim, Kyung-Hee
RA   Jeon, You-Kyung
RA   Kim, Sung-Hee
RA   Shin, Young-Kyoung
RA   Noh, Dong-Young
RA   Im, Seock-Ah
RA   Bang, Yung-Jue
RA   Han, Wonshik
RA   Kim, Woo-Ho
RA   Park, Jae-Gahb
RT   "Establishment and characterization of seven human breast cancer cell
RT   lines including two triple-negative cell lines.";
RL   Int. J. Oncol. 43:2073-2081(2013).
//